Letters
Post-marketing surveillance is needed for off licence use of drugs in children
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7391.712/a (Published 29 March 2003) Cite this as: BMJ 2003;326:712
- Michael Tettenborn (mtettenborn@doctors.org.uk), consultant in paediatrics and child health
- Frimley Children's Centre, Frimley GU16 7AD
EDITOR—Sutcliffe's editorial on the issue of testing pharmaceutical products in children addresses a longstanding problem for which there has been much talk but no solution.1 Although not likely to produce the quality of data that would come from formal trials in children, an alternative approach is to develop a …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.